Strengthening Medicine Supply Chain: Tracking Critical Imported Drugs.
This Act aims to enhance the security of essential medicine supplies for citizens by creating a confidential list of imported drugs critical to public health. The government will track the origin of these drugs and their ingredients to identify vulnerabilities in the supply chain, particularly those related to foreign production. Although the list will not be public, its purpose is to protect patients from shortages of chronic disease medications and emergency countermeasures.
Key points
Creation of Critical Imported Drug List: The government will compile and update a list of drugs essential for consumer health and safety, including those for chronic conditions and qualified countermeasures.
Monitoring Drug Origin: The list will include information on foreign manufacturing facilities and active ingredients to assess the risk of shortages and reliance on foreign suppliers.
Confidential Information: Most information (including the list of critical drugs and their manufacturers) will be confidential and shared only with national security agencies to evaluate threats.
Public Disclosure of Top Importing Countries: A list of the top 3 countries from which the U.S. imports critical drugs will be publicly disclosed, without revealing specific product details.
Expired
Citizen Poll